To view this email as a web page, click here.

 
To celebrate the 40th Anniversary of Dermatology Times, we asked our Editorial Advisory Board members to reflect on the publication and how the practice of dermatology has changed over the past 40 years. Read their insights below.
 
Reflections on the 40th Anniversary
image description here "Just after having finished my Mohs Surgery fellowship at the Cleveland Clinic Foundation, I was approached to join the Editorial Advisory Board by one of my patients who, at the time, was the Managing Editor for Dermatology Times…He asked me if I would be interested in helping to oversee a new dermatology publication," recalls Dr. Ronald Wheeland. Read more about his experience in this article.

 
Dermatology Times at 40
image description here "As Dermatology Times celebrates 40 years of continuous publication, it gives those of us who have been expressing our uncensored opinion an opportunity to thank this important magazine for allowing us to say things in public that almost no other similar vehicle would consider," says Dr. Norman Levine. Read more of his thoughts in this article.

 
From the Dermatology Times team

It has been our pleasure to bring you highlights from meetings, analysis of research advances, and varying perspectives on the changing regulatory landscape over the past 40 years. And we have appreciated your feedback along the way. Whether it was “great job!” or “you could’ve done that better,” we’ve valued it all, and we’ve based changes on your insights.

Over the next several months, we will include a mix of commentaries and articles reflecting on the past 40 years of our involvement in this ever-evolving specialty of dermatology. If you’d like to contribute, please email us.

Thank you for your continued engagement and support!
 
From our Latest Issue
 
Dermatology Times cover
Radiation therapy resurfaces in skin cancer treatment
 
How to advocate for the future of dermatology
 
Tips to minimize audit stress
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.